PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
A Prospective Clinical Study of Phenylketonuria (PKU)
Kuvan®’s Effect on the Cognition of Children With Phenylketonuria
Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
You're leaving the BioMarin Clinical Trials website.
This will take you to BioMarin.com, our global corporate website. Some of the information on BioMarin.com is intended for U.S. audiences only.
Leave this website
Close
You’re leaving the BioMarin Clinical Trials website.
Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.
Leave this website
Close
